Precigen to participate in upcoming leading investor and industry conferences

Germantown, md. , sept. 19, 2023 /prnewswire/ -- precigen, inc. (nasdaq: pgen), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced helen sabzevari, phd, president and ceo of precigen, will participate in the following upcoming investor and industry conferences: cantor global healthcare conference 2023 fireside chat on tuesday, september 26 at 4:55 pm et new york, ny cell & gene meeting on the mesa company presentation on wednesday, october 11, 2023 at 3:30 pm pt carlsbad, ca cantor aml virtual panel panel discussion on acute myeloid leukemia (aml) on thursday, october 26, 2023 at 2:00 pm et virtual participants may view details for these events through precigen's website in the events & presentations section at investors.precigen.com/events-presentations.
PGEN Ratings Summary
PGEN Quant Ranking